The Global Onychomycosis Treatment Market is forecasted to grow by USD 1,776.53 mn during 2022-2027, accelerating at a CAGR of 7.44% during the forecast period
Global Onychomycosis Treatment Market 2023-2027. The onychomycosis treatment market is forecasted to grow by USD 1,776.53 mn during 2022-2027, accelerating at a CAGR of 7.44% during the forecast period.
New York, July 10, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Onychomycosis Treatment Market 2023-2027" - https://www.reportlinker.com/p06474299/?utm_source=GNW
The report on the onychomycosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of onychomycosis, increasing awareness of onychomycosis treatment, and the growing aging population.
*The onychomycosis treatment market is segmented as below:*
By Type
• Pharmacological
• Non-pharmacological
By Distribution Channel
• Offline
• Online
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the increasing demand for topical treatment for onychomycosis as one of the prime reasons driving the onychomycosis treatment market growth during the next few years. Also, advancements in technology in onychomycosis treatment and increasing adoption of combination therapies for the treatment of onychomycosis will lead to sizable demand in the market.
The report on the onychomycosis treatment market covers the following areas:
• Onychomycosis treatment market sizing
• Onychomycosis treatment market forecast
• Onychomycosis treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading onychomycosis treatment market vendors that include Alembic Pharmaceuticals Ltd., Almirall SA, Astellas Pharma Inc., Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Fotona d.o.o, Galderma SA, GlaxoSmithKline Plc, Kaken Pharmaceutical Co. Ltd., Lupin Ltd., Medimetriks Pharmaceuticals Inc., Moberg Pharma AB, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., and The OTClab B.V.. Also, the onychomycosis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Read the full report: https://www.reportlinker.com/p06474299/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001